These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37244138)

  • 1. Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use of CPAP.
    Bogan RK; Maynard JP; Neuwirth R; Faessel H; Swick T; Olsson T
    Sleep Med; 2023 Jul; 107():229-235. PubMed ID: 37244138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia.
    Mignot E; Bogan RK; Emsellem H; Foldvary-Schaefer N; Naylor M; Neuwirth R; Faessel H; Swick T; Olsson T
    Sleep; 2023 Sep; 46(9):. PubMed ID: 36883238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationships between improvements in daytime sleepiness, fatigue and depression and psychomotor vigilance task testing with CPAP use in patients with obstructive sleep apnea.
    Bhat S; Gupta D; Akel O; Polos PG; DeBari VA; Akhtar S; McIntyre A; Ming SX; Upadhyay H; Chokroverty S
    Sleep Med; 2018 Sep; 49():81-89. PubMed ID: 30093261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP: A Randomized Trial.
    Pépin JL; Georgiev O; Tiholov R; Attali V; Verbraecken J; Buyse B; Partinen M; Fietze I; Belev G; Dokic D; Tamisier R; Lévy P; Lecomte I; Lecomte JM; Schwartz JC; Dauvilliers Y;
    Chest; 2021 Apr; 159(4):1598-1609. PubMed ID: 33121980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y; Takasaki Y; Yamashiro Y
    J Clin Sleep Med; 2013 Aug; 9(8):751-7. PubMed ID: 23946704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals.
    Evans R; Kimura H; Nakashima M; Ishikawa T; Yukitake H; Suzuki M; Hazel J; Faessel H; Wu J; Hang Y; Alexander R; Rosen L; Hartman DS; Ratti E
    J Sleep Res; 2023 Oct; 32(5):e13878. PubMed ID: 36934366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related impact of illness associated with excessive daytime sleepiness in patients with obstructive sleep apnea.
    Grandner MA; Min JS; Saad R; Leary EB; Eldemir L; Hyman D
    Postgrad Med; 2023 Jun; 135(5):501-510. PubMed ID: 37129416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Efficacy and Safety of Pitolisant for Residual Sleepiness Due to OSA.
    Pépin JL; Attali V; Caussé C; Verbraecken J; Hedner J; Lecomte I; Tamisier R; Lévy P; Lehert P; Dauvilliers Y
    Chest; 2024 Mar; 165(3):692-703. PubMed ID: 37979718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world impact of continuous positive airway pressure on sleepiness in patients with obstructive sleep apnea in a national registry.
    Jennum P; Kjellberg J; Carls G; Ibsen R; Mettam S
    Sleep Med; 2024 Jun; 118():93-100. PubMed ID: 38657350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.
    Dauvilliers Y; Verbraecken J; Partinen M; Hedner J; Saaresranta T; Georgiev O; Tiholov R; Lecomte I; Tamisier R; Lévy P; Scart-Gres C; Lecomte JM; Schwartz JC; Pépin JL;
    Am J Respir Crit Care Med; 2020 May; 201(9):1135-1145. PubMed ID: 31917607
    [No Abstract]   [Full Text] [Related]  

  • 12. Placebo response in objective and subjective measures of hypersomnia in randomized clinical trials on obstructive sleep apnea. A systematic review and meta-analysis.
    Labarca G; Montenegro R; Oscullo G; Henriquez-Beltran M; Uribe JP; Gómez-Olivas JD; Garcia-Ortega A; Martínez-García MÁ
    Sleep Med Rev; 2023 Feb; 67():101720. PubMed ID: 36495752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual Daytime Sleepiness in Obstructive Sleep Apnea After Continuous Positive Airway Pressure Optimization: Causes and Management.
    Chapman JL; Serinel Y; Marshall NS; Grunstein RR
    Sleep Med Clin; 2016 Sep; 11(3):353-63. PubMed ID: 27542881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CPAP vs. mandibular advancement device for excessive daytime sleepiness, fatigue, mood, sustained attention, and quality of life in patients with mild OSA.
    Luz GP; Badke L; Nery LE; Silva LO; Guimarães TM; Coelho G; Millani A; Alves RG; Kase C; Tufik S; Bittencourt L
    Sleep Breath; 2023 Jun; 27(3):991-1003. PubMed ID: 35948843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y; Miki M; Tabata T
    Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Outcomes in Adults with Coronary Artery Disease and Obstructive Sleep Apnea with versus without Excessive Daytime Sleepiness in the RICCADSA Cinical Trial.
    Eulenburg C; Celik Y; Redline S; Thunström E; Glantz H; Strollo PJ; Peker Y
    Ann Am Thorac Soc; 2023 Jul; 20(7):1048-1056. PubMed ID: 36800433
    [No Abstract]   [Full Text] [Related]  

  • 20. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.